Quantifying motor neuron loss in ALS.
Narasimhan
Kalyani
K
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D015984:Causality; D020934:Ciliary Neurotrophic Factor / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D015778:Minor Histocompatibility Antigens; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009410:Nerve Degeneration / Q000378:metabolism* / Q000503:physiopathology / Q000517:prevention & control; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism
C096816:BCL2-related protein A1; D020934:Ciliary Neurotrophic Factor; D015778:Minor Histocompatibility Antigens; D019253:Proto-Oncogene Proteins c-bcl-2